New cancer drug enters first human trials for Tough-to-Treat cancers
Disease control
Not yet recruiting
This is the first study in humans testing an experimental drug called CTX-10726 for several advanced cancers that have stopped responding to standard treatments. Researchers will give increasing doses to 70 patients to check safety, determine the best dose, and see if the drug sh…
Phase: PHASE1 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC